Meet ICON at CPHI
6 - 8 October, Milan, Italy, Booth #8F70
Reduce drug development timelines and improve clinical outcomes with ICON's Manufacturing & Pharmacy Services
ICON’s provides a seamless, end-to-end approach to formulation development and optimisation for small molecules and biologics. Our comprehensive manufacturing & pharmacy services cover everything from formulation screening and optimisation to analytical method development validation, and custom packaging, labelling, and distribution—including specialised support for oncology drugs and carbon-14 labelled products.
With GMP-compliant manufacturing sites equipped with on-site GMP Quality Control (QC) laboratories, we streamline formulation development and stability/compatibility studies, enabling faster early clinical manufacturing for early phase studies in both healthy volunteers and patients across Europe and the U.S.
Meet our experts at CPHI (Booth #8F70) to learn how our full suite of solutions can support your clinical development programme:
Arjen Akkerman
Arjen’s expertise spans oral and parenteral formulations, including radiolabelled investigational medicinal products (IMPs) for early phase clinical trials, as well as microdose and microtracer formulations. He provides global CMC support to operational and business development teams and is an experienced GMP and QP auditor.
Mindy Findlay
Mindy is an accomplished pharmacy leader with over 20 years of experience in clinical research, specializing in early phase development and cGMP-compliant pharmacy operations. As Pharmacy Manager in San Antonio, she oversees sterile and non-sterile compounding, investigational product management, and regulatory readiness, ensuring the highest standards of quality and compliance.
Gabriel Bohl
With more than 30 years of experience in Regulatory Affairs, including 25 years in CMC and 15 years focused on large and innovative molecules, Gabriel is a highly experienced regulatory professional specialising in biologics, vaccines, advanced therapy medicinal products (ATMPs), cell and gene therapies (CGTs), and other complex biological products.
Meet our experts
Submit our short form to request a meeting with one of our experts at CPHI